Innovative Strategies for MedTech Success
Unlock new opportunities in the D-A-CH region with tailored
market-entry strategies and value-driven solutions.
Do you want to achieve maximum success in the medical technology industry in the D-A-CH region?
We create success in MedTech²
From market entry to measurable revenue in Germany, Austria and Switzerland – powered by the Reverse-Sales® Code.
We know the problems. We know the market. We know the rules. We are at home here.
Why many D-A-CH plans stall
Fragmented vendors, hand-off losses and unclear value stories cause long decision cycles and missed deals.
In D-A-CH, clinical benefit, economic logic and regulatory fit must align. Without orchestration, market entry consumes time, budget and trust.
We know the market.
One integrated A-to-Z team
We act as success creators for MedTech hidden champions: strategy, communication, design, sales ops, partnering and implementation – integrated, not accumulated. No hand-offs. One point of contact.
Our promise: clear value, solid evidence and disciplined execution until the pipeline performs.
Who we serve
- MedTech startups and scale-ups targeting D-A-CH.
- International manufacturers with complex, high-explain solutions.
- Hidden champions aligning go-to-market, reimbursement and hospital economics.
- Companies that have developed solutions in the field of AI.
- Innovative companies that need reliable partners.
11+1 phases to success (Reverse-Sales® Code)
Learn how our integrated team works in a structured manner to achieve optimal results for our customers.
Phase 1
In-depth analyses – market, indication, reimbursement, buying center.
Phase 2
Evaluation – patterns, opportunities, gaps.
Phase 3
Knowledge gain – value hypotheses, proof requirements.
Phase 4
Unlimited creativity – story, claim, formats, go-to-market approaches.
Phase 5
Resource-oriented planning – roles, budget, milestones.
Phase 6
Tailored strategies – DACH-Fit per segment.
Phase 7
Action plans – playbooks, scripts, assets.
Phase 8
Evaluation – tests, pilot sites, KOL feedback.
Phase 9
Learning from successful steps – what works, what doesn’t.
Phase 10
Implementation – partnering, enablement, processes.
Phase 11
Implementation until success – references, scaling, pipeline.
Plus 1
Honest, fair, partnership-oriented – with heart and clarity.
Your gains in 5 bullets
Achieve measurable success within weeks with our targeted strategies.
1
Faster decision readiness across the buying center (clinical & economic).
2
Less friction
thanks to a single integrated team.
3
Proof over belief: pilot sites, references and solid mini business cases.
4
Time efficiency through clear playbooks, processes and sales enablement.
5
A scalable D-A-CH pipeline – from first meeting to roll-out.
What we are NOT (and why that helps you)
We are not a classic consultancy, not an agency, not mere sales trainers, not headhunters, not interim managers and not a call center.
We integrate all these roles in a single team – no hand-offs, no friction, full outcome ownership.
Services (selection)
D-A-CH market-entry audit: product/indication fit, reimbursement paths, buying center, risk heatmap, go/refine/stop.
Value story & MMF: decision-maker clarity – clinical, economic, strategic.
Reimbursement & hospital economics: mini business case, DRG/OPS/EBM/GOÄ path, TCO/ROI.
Access & partnering: KOL network, reference sites, trade-fair-to-meeting converter (e.g. MEDICA).
Sales ops & enablement: champion script, objection library, follow-up flows, deal reviews.
Executive sparring (values × growth): guardrails, pricing, conflict moderation.
How we work
One team, one responsibility: we integrate consulting, agency work, training, recruiting levers and interim leadership in one setup.
Clarity & evidence: decisions are based on data, tests and defensible proof points.
Focus & execution: structured sprints, defined milestones, disciplined follow-up.
Values-driven: honest, fair, partnership-oriented – with heart and clarity.
Outcomes & KPIs (illustrative)
3–5 executive meetings per target segment within 6–8 weeks
1–2 pilot sites with defined success criteria and reference story
MMF maturity & deal quality tracked via scorecards
READY TO ACCELERATE IN D-A-CH?
More than 30 years of experience with consulting-intensive capital goods in medtech. We do everything with heart and mind—because that’s the least we want to give our customers.
Take the opportunity to develop your individual market entry plan in a non-binding consultation. Discover how you can get off to a successful start in the D-A-CH region with targeted strategies and measurable milestones. Book your appointment.